InstaMed (J.P. Morgan)

Healthcare payments network connecting providers, payers, and patients

Our take

InstaMed is a healthcare payments network founded in Philadelphia in 2004 by Bill Marvin and Chris Seib, and acquired by JPMorgan Chase in 2019 for more than $500 million, the bank's largest acquisition since 2008. The platform connects providers, payers, and patients: patient payments online and at point of service, payer electronic remittance and funds transfer, eStatements, saved payment methods, and eligibility. Its Epic integration is a signature strength, letting health systems collect inside MyChart and Community Connect workflows with InstaMed acting as gateway, processor, and sponsor bank in one.

As the payments arm of J.P. Morgan's healthcare business, InstaMed serves named customers including Mercy Health System, University of Rochester Medical Center, Boston Children's Hospital, and Catholic Health, and says more than half of US provider organizations are on its network. Its annual Trends in Healthcare Payments report, now in its fourteenth year, has become a standard industry reference. Buyers choosing InstaMed are usually consolidating patient payments, payer payments, and banking with one large, stable counterparty rather than assembling point solutions.

What it does

Patient payment collection online, mobile, and point of service
Epic MyChart bill pay integration
Payer-to-provider electronic payments (ERA/EFT)
Digital wallets and saved payment methods (Secure Token)
eStatements and paperless billing
Real-time eligibility and claims connectivity

Where it's strong

Combined gateway, processor, and sponsor bank in one vendor, backed by J.P. Morgan's balance sheet and payments infrastructure.
One of the deepest Epic payment integrations on the market, with documented results like Mercy's 143% jump in online payment adoption.
Network scale: over half of US provider organizations touch the InstaMed network, which helps with payer connectivity.

What buyers should weigh

Post-acquisition, InstaMed is a product line inside a giant bank, so roadmap pace and support attention can feel corporate rather than startup-responsive.
Best economics and experience assume you consolidate processing with J.P. Morgan; mixing acquirers gets less attractive.
Contract pricing is negotiated and opaque; smaller groups have less leverage than the enterprise health systems the sales motion favors.

Latest

J.P. Morgan Healthcare Payments published its fourteenth annual Trends in Healthcare Payments report, citing 136% growth in eStatement transactions from 2022 to 2025 on the InstaMed network.